Key facts
- This page summarizes John W. LaRocca's Form 3 filing for Y-mAbs Therapeutics, Inc. (YMAB).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Jan 2025, 16:44.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
The stock option shall vest and become exercisable as to 25% of the shares subject to the option on January 18, 2025, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
SEC remarks
Exhibit 24 - Power of Attorney